➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Johnson and Johnson
Merck
Boehringer Ingelheim
Harvard Business School

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Sagent Pharms Inc Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?

SAGENT PHARMS INC has forty-six approved drugs.



Summary for Sagent Pharms Inc
US Patents:0
Tradenames:40
Ingredients:39
NDAs:46

Drugs and US Patents for Sagent Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms Inc DAPTOMYCIN daptomycin POWDER;IV (INFUSION) 208385-001 Sep 12, 2017 AP RX Yes Yes   Start Trial   Start Trial
Sagent Pharms Inc DESMOPRESSIN ACETATE desmopressin acetate INJECTABLE;INJECTION 204695-001 Aug 22, 2017 AP RX No No   Start Trial   Start Trial
Sagent Pharms Inc ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 091458-002 Jul 28, 2010 AP RX No No   Start Trial   Start Trial
Sagent Pharms Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090581-001 Oct 20, 2015 AP RX No No   Start Trial   Start Trial
Sagent Pharms Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090583-003 Nov 27, 2015 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
McKinsey
AstraZeneca
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.